Astellas Pharma To Acquire Iveric Bio In $5.9 Bln Deal
1/5 03:12
(RTTNews) - Astellas Pharma Inc. (ALPMY, ALPMY) agreed to acquire Iveric bio Inc. (ISEE) for US$40.00 per share in cash, representing a total equity value of about US$5.9 billion....
|
|
|
1/5 03:12
(RTTNews) - Astellas Pharma Inc. (ALPMY, ALPMY) agreed to acquire Iveric bio Inc. (ISEE) for US$40.00 per share in cash, representing a total equity value of about US$5.9 billion....